[Evaluation of taking mifepristone at home during a medical abortion]
Swedish Agency for Health Technology Assessment and Assessment of Social Services
Record ID 32018002307
English
Original Title:
Utvärdering av att ta det första läkemedlet (mifepriston) utanför vårdinrättning vid medicinsk abort
Authors' objectives:
SBU has been commissioned by the Swedish government to review the positive and negative effects of going through the medical abortion at home. A medical abortion consists of two drugs taken 24-48 hours a part. In Sweden women take the first drug at a clinic and today most women choose to take the second drug at home.
Details
Project Status:
Completed
Year Published:
2023
URL for published report:
https://www.sbu.se/363e
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
Sweden
MeSH Terms
- Pregnancy
- Abortion, Legal
- Abortion, Induced
- Abortifacient Agents, Nonsteroidal
- Misoprostol
Keywords
- Pregnancy
- Abortion
- Medical abortion
Contact
Organisation Name:
Swedish Agency for Health Technology Assessment and Assessment of Social Services
Contact Address:
SBU – Swedish Agency for Health Technology Assessment and Assessment of Social Services, P.O. Box 6183, SE-102 33 Stockholm, Sweden. Tel: +46 8 4123200, Fax: +46 8 4113260
Contact Name:
registrator@sbu.se
Contact Email:
registrator@sbu.se
Copyright:
SBU – Swedish Agency for Health Technology Assessment and Assessment of Social Services
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.